Community/Retail

With flu season just around the corner, it is important for pharmacists to be up-to-date on the latest recommendations.

A recent study suggests that vaccination rates in some Texas schools are low enough to allow for large measles outbreaks, but limiting vaccine exemptions could decrease this risk. Vaccine exemptions, which allow unvaccinated children to attend school, have increased by a factor of 28 since 2003 in Texas.

This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.

The newly approved therapy is equivalent to AstraZeneca Pharmaceuticals’ Faslodex injection, 250mg/5mL.

Community Pharmacy Consultant Bruce Kneeland speaks with Kevin DeMass, RPh, President of Apothecary Shoppe, Salt Lake City, UT, discusses communication with patients' caregivers and family members.

A recent CDC study found that although teen vaccine coverage has improved, more education and provider recommendations are needed to boost immunization rates for human papillomavirus (HPV).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Tera Moore, PharmD, explains the importance of full integration for psychiatric pharmacist providers across the full mental health continuum of care.

Julie Johnson, PharmD, Dean of the University of Florida College of Pharmacy, discusses how practicing pharmacists can implement and use precision medicine in their everyday work.

The FDA has published a warning letter sent to Ningbo Huize Commodity, an over-the-counter drug manufacturer, citing significant current good manufacturing practice (CGMP) violations including data integrity issues.

Despite e-commerce disruptions to the industry, a recent study found that the United States pharmacy industry continues to maintain high levels of customer satisfaction in both the brick-and-mortar and mail order segments.

Erin Fox, PharmD, BCPS, FASHP will be presenting the American Society of Health-System Pharmacists (ASHP) tenth annual William A. Zellmer Lecture on September 10, 2019, as recipient of the 2019 Zellmer Lecture Award.

Videos, podcasts, articles, and apps are readily available at our fingertips (literally) to help pharmacy students comprehend difficult subjects.

Suzy Soliman, PharmD, founder of the Pharmacist Moms Group, discusses the goals she has for the online community and what its members can accomplish.

In recent months, legislation to increase access to pre- and post-exposure prophylaxis (PrEP and PEP) passed in California with a vote of 34-1 in the Senate and a unanimous vote in the Assembly.

Dennis Killian, PharmD, PhD, discusses how implementing IV robotics has improved safety at Peninsula Regional Medical Center.

Officials with the FDA have approved AbbVie’s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).

Suzy Soliman, PharmD, explains the various ways in which pharmacist moms communicate within their community.

Stay tuned for upcoming coverage on the NACDS Total Store Expo in Boston, MA, August 24-26.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The dug will be commercially available to healthcare professionals and appropriate patients in the U.S. in the fourth quarter of 2019.

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses considerations when making the switch to IV robotics.

Cladosporium, Penicillium, Alternaria, and Aspergillus are the most common molds found in almost all environments.1 These are just a few of the hundreds of thousands of species of fungi.

Officials with the FDA have approved Alembic Pharmaceuticals’ Fenofibrate Tablets USP, 48 mg and 145 mg as an adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B).

Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).

Suzanne Soliman, PharmD, founder of the Pharmacist Moms Group, talks about her hopes for the future of the online community.

Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.

In an ideal world, how would you hypothesize that technology might be able to solve all of your problems?